Login / Signup

Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.

Laurent BéchardOlivier CorbeilMaude PlanteMarc-André ThiviergeCharles-Émile LafrenièreMarc-André RoyMarie-France Demers
Published in: Journal of psychopharmacology (Oxford, England) (2021)
These results suggest that the "as-needed" use of G-CSF is well-tolerated and may allow clozapine rechallenge in some well-selected patients, adding to the paucity of data regarding long-term safety and efficacy of this strategy. More research may help to better define potential candidates and optimal regimen of such practice.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • primary care
  • healthcare
  • prognostic factors
  • peripheral blood
  • chemotherapy induced